Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nadia Belmatoug
Impact of Imiglucerase Supply Constraint on the Therapeutic Management and Course of Disease in French Patients With Gaucher Disease Type 1
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Related publications
Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse Model
PLoS ONE
Multidisciplinary
Assessment of Bone Health in Patients With Type 1 Gaucher Disease Using Impact Microindentation
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
Long-Term Clinical Outcomes in Type 1 Gaucher Disease Following 10 Years of Imiglucerase Treatment
Journal of Inherited Metabolic Disease
Genetics
High Incidence of Cholesterol Gallstone Disease in Type 1 Gaucher Disease: Characterizing the Biliary Phenotype of Type 1 Gaucher Disease
Journal of Inherited Metabolic Disease
Genetics
The Clinical Management of Type 2 Gaucher Disease
Molecular Genetics and Metabolism
Genetics
Molecular Biology
Biochemistry
Endocrinology
Metabolism
Diabetes
Review of the Safety and Efficacy of Imiglucerase Treatment of Gaucher Disease
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Russian Pediatric Experience on Assessing the Effectiveness of Imiglucerase for Long-Term Enzyme Replacement Therapy of Gaucher Disease Type 1 in Children
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
Medicine
Endocrine and Metabolic Disorders in Patients With Gaucher Disease Type 1: A Review
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Psy51 - Clinical and Economic Aspects of Enzyme Replacement Therapy in Russian Patients With Gaucher Disease Type 1
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
